Paragon Biosciences bought a cancer diagnostic tool developed by ITM researcher Maryellen Giger, PhD, in an eight-figure deal. The software, called QuantX, uses computer imaging to help doctors quickly and accurately identify your breast cancer. Its further development could go on to help diagnose other types of cancer.
Click here to read more about the diagnostic tool, which was approved by the FDA in 2017.
